BDBM99207 US8501708, 31

SMILES CC(C)c1ccc(CO[C@@H]2CCCC2Nc2ncnc3n(cnc23)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1

InChI Key InChIKey=HEHPEMPIIGZAPY-JSNTWKLXSA-N

Data  3 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 99207   

TargetAdenosine receptor A1(Rabbit)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99207(US8501708, 31)
Affinity DataKi:  6.08nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetAdenosine receptor A3(Rabbit)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99207(US8501708, 31)
Affinity DataKi:  3.71E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetAdenosine receptor A2(Rabbit)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99207(US8501708, 31)
Affinity DataKi:  3.78E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent